RSSDepartments

CNS Summit 2018 Abstract Supplement Digital Edition

CNS Summit 2018 Abstract Supplement Digital Edition

| November 1, 2018

Click the cover below to access the CNS Summit 2018 Abstract Supplement digital edition!

Continue Reading

CNS Summit 2018 Abstracts of Poster Presentations

CNS Summit 2018 Abstracts of Poster Presentations

| November 1, 2018

A message from the editor: Dear Colleagues: Welcome to the annual CNS Summit Abstracts of Poster Presentations supplement to Innovations in Clinical Neuroscience. We are pleased to provide you with this reference guide to some of the innovative research that is being presented during CNS Summit 2018. The supplement is also available online by visiting […]

Continue Reading

Editorial Message and Issue Highlights–Vol. 15, No. 11–12, November-December 2018

Editorial Message and Issue Highlights–Vol. 15, No. 11–12, November-December 2018

| November 1, 2018

Dear Colleagues: Welcome to the November–December issue of Innovations in Clinical Neuroscience (ICNS). We start this issue with an article by Aboraya et al titled “Measurement-based Care in Psychiatry—Past, Present, and Future.” Here the authors define and describe measurement-based care (MBC) in psychiatry as well discuss the research supporting its use in clinical practice. Barriers […]

Continue Reading

Measurement-based Care in Psychiatry— Past, Present, and Future

Measurement-based Care in Psychiatry— Past, Present, and Future

| November 1, 2018

by Ahmed Aboraya, MD, Dr.PH; Henry A. Nasrallah, MD; Daniel E. Elswick, MD; Ahmed Elshazly, MD; Nevine Estephan, MD; Dalia Aboraya, BA; Seher Berzingi; Josleen Chumbers; Aara Berzingi, BA; John Justice, MD; Jawad Zafar, DO; and Sheena Dohar, MD Dr. Aboraya is Chief of Psychiatry at William R. Sharpe, Jr. Hospital, Clinical Professor of Psychiatry […]

Continue Reading

Validation of an Equation Model to Predict Intracranial Pressure in Clinical Studies

Validation of an Equation Model to Predict Intracranial Pressure in Clinical Studies

| November 1, 2018

by Niro Kasahara, MD; Mateus L. Matuoka, MD; Katia S. Santos, MD; Natasha F.S. Cruz, MD; Alvaro R. Martins, MD; and Stanley Nigro, MD Drs. Kasahara, Matuoka, Santos, and Cruz are with the Department of Ophthalmology, Irmandade da Santa Casa de Misericordia de Sao Paulo in Sao Paulo, Brazil. Dr. Kasahara is also with Santa […]

Continue Reading

It’s Nice to Be Nice, But…A Little Risk Management Can Go a Long Way in Reducing Your Liability Risk

It’s Nice to Be Nice, But…A Little Risk Management Can Go a Long Way in Reducing Your Liability Risk

| November 1, 2018

by Donna Vanderpool, MBA, JD Ms. Vanderpool is Vice President at PRMS, Inc. in Arlington, Virginia. Funding: No funding was provided for the preparation of this article. Disclosures: The author is an employee of PRMS Inc., a risk management consulting company for healthcare providers. Innov Clin Neurosci. 2018;15(11–12):36–38 This ongoing column is dedicated to providing […]

Continue Reading

Letter to the Editor: When “Cure” becomes “Care” in Robotic Neurorehabilitation: The Critical Role of Nurses in a Novel Sicilian Multidisciplinary Approach

Letter to the Editor: When “Cure” becomes “Care” in Robotic Neurorehabilitation: The Critical Role of Nurses in a Novel Sicilian Multidisciplinary Approach

| November 1, 2018

By Alfredo Manuli, MSc, and Rocco Salvatore Calabrò, MD, PhD Funding/financial disclosures. The authors have no conflicts of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Innov Clin Neurosci. 2018;15(11–12):11–12 Dear Editor: The goal of rehabilitation is to assist individuals with disability and/or chronic illness in […]

Continue Reading

Letter to the Editor: The Ever-changing Landscape of the Opioid Crisis: Fentanyl and its Analogs

Letter to the Editor: The Ever-changing Landscape of the Opioid Crisis: Fentanyl and its Analogs

| November 1, 2018

By Adegboyega Oyemade, MD, FAPA Funding/financial disclosures. The author has no conflict of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Innov Clin Neurosci. 2018;15(11–12):11–12 Dear Editor: Fentanyl was created in 1960 as an intravenous surgical anesthetic (Sublimaze®, Janssen Pharmaceuticals Inc.), which is 50 to 100 […]

Continue Reading